Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Symbotic Inc
Symbotic Reports Fourth Quarter and Fiscal Year 2025 Results
Business
Nov 24 2025
22 min read

Symbotic Reports Fourth Quarter and Fiscal Year 2025 Results

news images

WILMINGTON, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, announced financial results for its fourth fiscal quarter and fiscal year 2025, which ended on September 27, 2025. Symbotic reported revenue of $618 million, a net loss of $19 million and adjusted EBITDA1 of $49 million for the fourth quarter of fiscal year 2025.

In comparison, Symbotic posted revenue of $565 million, net income of $16 million and adjusted EBITDA1 of $42 million in the fourth quarter of fiscal year 2024.

Cash and cash equivalents increased by $467 million from the prior quarter, totaling $1,245 million at the end of the fourth quarter of fiscal year 2025.

For the full fiscal year 2025, Symbotic reported revenue of $2,247 million, reflecting 26% growth year-over-year, a net loss of $91 million, and adjusted EBITDA1 of $147 million.

“We delivered on our commitments to achieve strong top-line growth, a significant rise in operational systems, and strong margin expansion in fiscal year 2025 as we continue to enhance our value to customers,” said Rick Cohen, Symbotic Chairman and Chief Executive Officer. “We also added Medline, our first customer in the health care vertical, and enter fiscal year 2026 enthusiastic about our prospects to broaden opportunities with customers.”

“Revenue exceeded our expectations, and we delivered strong gross margin expansion and free cash flow in the fiscal fourth quarter of 2025,” said Izzy Martins, Symbotic Chief Financial Officer. “Looking ahead, the start of fiscal year 2026 is unfolding consistent with the expectations we outlined last quarter as our customers continue their transition to our next generation storage structure.”

OUTLOOK

For the first quarter of fiscal 2026, Symbotic expects revenue of $610 million to $630 million, and adjusted EBITDA2 of $49 million to $53 million.

WEBCAST INFORMATION

Symbotic will host a webcast today at 5:00 pm ET to discuss its fourth quarter and fiscal year 2025 results. The webcast link is: https://edge.media-server.com/mmc/go/Symbotic-Q4-2025.

________________________________
1 Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) is a non-GAAP financial measure as defined below under “Use of Non-GAAP Financial Information.” See the tables below for reconciliations to net income (loss), the most comparable GAAP measure.

2 Symbotic is not providing guidance for net income (loss), which is the most comparable GAAP financial measure to adjusted EBITDA, because information reconciling forward-looking adjusted EBITDA to net income (loss) is unavailable to it without unreasonable effort. Symbotic is not able to provide reconciliations of adjusted EBITDA to GAAP financial measures because certain items required for such reconciliations are outside of Symbotic’s control and/or cannot be reasonably predicted, such as the provision for stock-based compensation.


ABOUT SYMBOTIC

Symbotic is an automation technology leader reimagining the supply chain with its end-to-end, A.I.-powered robotic and software platform. Symbotic reinvents the warehouse as a strategic asset for the world’s largest retail, wholesale, and food & beverage companies. Applying next-generation technology, high-density storage and machine learning to solve today's complex distribution challenges, Symbotic enables companies to move goods with unmatched speed, agility, accuracy and efficiency. As the backbone of commerce, Symbotic transforms the flow of goods and the economics of the supply chain for its customers. For more information, visit www.symbotic.com.

USE OF NON-GAAP FINANCIAL INFORMATION

Symbotic reports its financial results in accordance with Generally Accepted Accounting Principles in the United States (“U.S. GAAP”). This press release contains financial measures that are not recognized under U.S. GAAP (“non-GAAP financial measures”), including adjusted EBITDA, adjusted gross profit, adjusted gross profit margin, adjusted research and development expenses, adjusted selling, general, and administrative expenses, and free cash flow. These non-GAAP financial measures have limitations as an analytical tool as they do not have a standardized meaning prescribed by U.S. GAAP. The non-GAAP financial measures Symbotic uses may not be the same non-GAAP financial measures, and may not be calculated in the same manner, as that of other companies and, therefore, are unlikely to be comparable to similar measures presented by other companies. Rather, these non-GAAP financial measures are provided as a supplement to corresponding U.S. GAAP measures to provide additional information regarding the results of operations from management’s perspective. Accordingly, non-GAAP financial measures should not be considered a substitute for, in isolation from, or superior to, the financial information prepared and presented in accordance with U.S. GAAP. All non-GAAP financial measures presented in this press release are reconciled to their closest reported U.S. GAAP financial measures. Symbotic recommends that investors review the reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures provided in the financial statement tables included below in this press release, and not rely on any single financial measure to evaluate its business.

Symbotic defines adjusted EBITDA, a non-GAAP financial measure, as GAAP net income (loss) excluding the following items: interest income; income taxes; depreciation and amortization of tangible and intangible assets; stock-based compensation; business combination transaction expenses; equity method investment; internal control remediation; business transformation costs; fair value adjustments on strategic investments; restructuring charges; joint venture formation fees; equity financing transaction costs; and other infrequent items that may arise from time to time. Symbotic defines adjusted gross profit, a non-GAAP financial measure, as GAAP gross profit excluding the following items: depreciation, stock-based compensation, and restructuring charges. Symbotic defines adjusted gross profit margin, a non-GAAP financial measure, as adjusted gross profit divided by total revenue. Symbotic defines adjusted research and development expenses, a non-GAAP financial measure, as GAAP research and development expenses excluding the following items: depreciation and amortization of tangible and intangible assets and stock-based compensation. Symbotic defines adjusted selling, general, and administrative expenses, a non-GAAP financial measure, as GAAP selling, general, and administrative expenses excluding the following items: depreciation and amortization of tangible and intangible assets; stock-based compensation; business combination transaction expenses; internal control remediation; business transformation costs; joint venture formation fees; equity financing transaction costs; and other infrequent items that may arise from time to time. Symbotic defines free cash flow, a non-GAAP financial measure, as net cash provided by or used in operating activities less purchases of property and equipment and capitalization of internal use software development costs. In addition to Symbotic’s financial results determined in accordance with U.S. GAAP, Symbotic believes that adjusted EBITDA, adjusted gross profit, adjusted gross profit margin, adjusted research and development expenses, adjusted selling, general, and administrative expenses, and free cash flow non-GAAP financial measures, are useful in evaluating the performance of Symbotic’s business because they highlight trends in its core business.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, but not limited to, Symbotic’s expectations or predictions of future financial or business performance or conditions. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning our possible or assumed future actions, business strategies, events, backlog or results of operations, are forward-looking statements. These statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates” or “intends” or similar expressions.

Forward-looking statements include, but are not limited to, statements about the ability of or expectations regarding, Symbotic to:

  • meet the technical requirements of existing or future supply agreements with its customers, including with respect to existing backlog;

  • expand its target customer base and maintain its existing customer base;

  • realize the benefits expected from our GreenBox Systems LLC (“GreenBox”) joint venture, the commercial agreement with GreenBox, the commercial agreement with Nueva Wal Mart de México, S. de R.L. de C.V and the acquisition of the Advanced Systems and Robotics business from Walmart;

  • realize its outlook, including its system gross margin;

  • anticipate industry trends;

  • maintain and enhance its system;

  • anticipate rapid technological changes;

  • execute its growth strategy;

  • develop, design and sell systems that are differentiated from those of competitors;

  • execute its research and development strategy;

  • acquire, maintain, protect and enforce intellectual property;

  • attract, train and retain effective officers, key employees or directors;

  • comply with laws and regulations applicable to its business;

  • stay abreast of modified or new laws and regulations applying to its business;

  • successfully defend litigation;

  • issue equity securities in connection with future transactions;

  • meet future liquidity requirements and, if applicable, comply with restrictive covenants related to long-term indebtedness;

  • timely and effectively remediate any material weaknesses in its internal control over financial reporting;

  • maintain the listing of the Symbotic common stock on Nasdaq; and

  • effectively respond to general economic and business conditions.


Forward-looking statements also include, but are not limited to, statements with respect to:

  • the future performance of Symbotic’s business and operations;

  • expectations regarding revenues, expenses, adjusted EBITDA and anticipated cash needs;

  • expectations regarding cash flow, liquidity and sources of funding;

  • the next generation storage structure;

  • expectations regarding capital expenditures;

  • the anticipated benefits of Symbotic’s leadership structure;

  • the effects of pending and future legislation, regulation and trade practices, including tariffs;

  • business disruption;

  • disruption to the business due to Symbotic’s dependency on Walmart;

  • increasing competition in the warehouse automation industry;

  • any delays in the design, production or launch of Symbotic’s systems and products;

  • the failure to meet customers’ requirements under existing or future contracts or customer’s expectations as to price or pricing structure;

  • any defects in new products or enhancements to existing products;

  • the fluctuation of operating results from period to period due to a number of factors, including the pace of customer adoption of Symbotic’s new products and services and any changes in its product mix that shift too far into lower gross margin products; and

  • any consequences associated with joint ventures and legislative and regulatory actions and reforms.

Such forward-looking statements involve risks and uncertainties that may cause actual events, results or performance to differ materially from those indicated by such statements. Certain of these risks are identified and discussed in Symbotic’s Annual Report on Form 10-K for the fiscal year ended September 27, 2025, filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 24, 2025. These risk factors will be important to consider in determining future results and should be reviewed in their entirety. These forward-looking statements are expressed in good faith, and Symbotic believes there is a reasonable basis for them. However, there can be no assurance that the events, results or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements are provided for the purposes of assisting the reader in understanding our financial performance, financial position and cash flows as of and for periods ended on certain dates and to present information about management’s current expectations and plans relating to the future, and the reader is cautioned not to place undue reliance on these forward-looking statements because of their inherent uncertainty and to appreciate the limited purposes for which they are being used by management. While we believe that the assumptions and expectations reflected in the forward-looking statements are reasonable based on information currently available to management, there is no assurance that such assumptions and expectations will prove to have been correct. Forward-looking statements speak only as of the date they are made and are based on the beliefs, estimates, expectations and opinions of management on that date. Symbotic is not under any obligation, and expressly disclaims any obligation to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Readers should carefully review the statements set forth in the reports that Symbotic has filed or will file from time to time with the SEC.

In addition to factors previously disclosed in Symbotic’s Annual Report on Form 10-K for the fiscal year ended September 27, 2025 filed with the SEC on November 24, 2025 and those identified elsewhere in this press release, the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance.

Any financial projections in this press release or discussed in the webcast are forward-looking statements that are based on assumptions that are inherently subject to significant uncertainties and contingencies, many of which are beyond Symbotic’s control. While all projections are necessarily speculative, Symbotic believes that the preparation of prospective financial information involves increasingly higher levels of uncertainty the further out the projection extends from the date of preparation. The assumptions and estimates underlying the projected results are inherently uncertain and are subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained in the projections. The inclusion of projections in this communication should not be regarded as an indication that Symbotic, or its representatives, considered or considers the projections to be a reliable prediction of future events.

Annualized, projected and estimated numbers are not forecasts and may not reflect actual results.

This communication is not intended to be all-inclusive or to contain all the information that a person may desire in considering an investment in Symbotic and is not intended to form the basis of an investment decision in Symbotic. The forward-looking statements contained in this press release and other reports we file with, or furnish to, the SEC and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf are expressly qualified in their entirety by these cautionary statements.

INVESTOR RELATIONS CONTACT

Charlie Anderson
Vice President, Investor Relations & Corporate Development
ir@symbotic.com

MEDIA INQUIRIES

mediainquiry@symbotic.com

 

 

Symbotic Inc. and Subsidiaries
Consolidated Statements of Operations

 

 

 

 

 

Three Months Ended

 

Year Ended

 (in thousands, except share and per share information)

September 27, 2025

 

June 28, 2025

 

September 28, 2024

 

September 27, 2025

 

September 28, 2024

Revenue:

 

 

 

 

 

 

 

 

 

Systems

$

582,329

 

 

$

559,108

 

 

$

536,447

 

 

$

2,118,868

 

 

$

1,705,440

 

Software maintenance and support

 

9,271

 

 

 

8,121

 

 

 

5,893

 

 

 

29,602

 

 

 

14,173

 

Operation services

 

26,857

 

 

 

24,892

 

 

 

22,226

 

 

 

98,452

 

 

 

68,566

 

Total revenue

 

618,457

 

 

 

592,121

 

 

 

564,566

 

 

 

2,246,922

 

 

 

1,788,179

 

Cost of revenue:

 

 

 

 

 

 

 

 

 

Systems

 

456,157

 

 

 

457,911

 

 

 

442,009

 

 

 

1,710,446

 

 

 

1,466,841

 

Software maintenance and support

 

2,827

 

 

 

1,756

 

 

 

2,748

 

 

 

8,562

 

 

 

8,949

 

Operation services

 

32,352

 

 

 

24,832

 

 

 

23,392

 

 

 

105,304

 

 

 

66,723

 

Total cost of revenue

 

491,336

 

 

 

484,499

 

 

 

468,149

 

 

 

1,824,312

 

 

 

1,542,513

 

Gross profit

 

127,121

 

 

 

107,622

 

 

 

96,417

 

 

 

422,610

 

 

 

245,666

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development expenses

 

58,732

 

 

 

52,147

 

 

 

40,130

 

 

 

216,013

 

 

 

173,457

 

Selling, general, and administrative expenses

 

83,638

 

 

 

75,670

 

 

 

45,399

 

 

 

298,730

 

 

 

188,934

 

Restructuring charges

 

6,513

 

 

 

16,361

 

 

 

 

 

 

22,873

 

 

 

 

Total operating expenses

 

148,883

 

 

 

144,178

 

 

 

85,529

 

 

 

537,616

 

 

 

362,391

 

Operating income (loss)

 

(21,762

)

 

 

(36,556

)

 

 

10,888

 

 

 

(115,006

)

 

 

(116,725

)

Other income, net

 

8,076

 

 

 

8,451

 

 

 

9,416

 

 

 

36,063

 

 

 

37,042

 

Income (loss) before income tax

 

(13,686

)

 

 

(28,105

)

 

 

20,304

 

 

 

(78,943

)

 

 

(79,683

)

Income tax benefit (expense)

 

423

 

 

 

(44

)

 

 

(4,110

)

 

 

1,627

 

 

 

(4,212

)

Loss from equity method investment

 

(5,885

)

 

 

(3,776

)

 

 

(240

)

 

 

(13,716

)

 

 

(777

)

Net income (loss)

 

(19,148

)

 

 

(31,925

)

 

 

15,954

 

 

 

(91,032

)

 

 

(84,672

)

Net income (loss) attributable to noncontrolling interests

 

(15,526

)

 

 

(26,012

)

 

 

13,118

 

 

 

(74,095

)

 

 

(71,182

)

Net income (loss) attributable to common stockholders

$

(3,622

)

 

$

(5,913

)

 

$

2,836

 

 

$

(16,937

)

 

$

(13,490

)

 

 

 

 

 

 

 

 

 

 

Income (loss) per share of Class A Common Stock:

 

 

 

 

 

 

 

 

 

Basic and Diluted(1)

$

(0.03

)

 

$

(0.05

)

 

$

0.03

 

 

$

(0.16

)

 

$

(0.14

)

Weighted-average shares of Class A Common Stock outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

111,697,093

 

 

 

109,201,745

 

 

 

104,146,479

 

 

 

108,670,159

 

 

 

95,697,368

 

Diluted (2)

 

n/a

 

 

 

n/a

 

 

 

108,646,977

 

 

 

n/a

 

 

 

n/a

 

 

(1) For the periods presented, basic and diluted EPS were calculated as the same value and as such presented on the same line.

(2) Periods in which the Company was in a net loss position diluted weighted-average shares of Class A Common Stock outstanding is the same as basic and as such indicated with “n/a”.


 

Symbotic Inc. and Subsidiaries
Reconciliation of Non-GAAP Financial Measures

 

The following table reconciles GAAP net income (loss) to Adjusted EBITDA:

 

 

Three Months Ended

 

Year Ended

(in thousands)

September 27, 2025

 

June 28, 2025

 

September 28, 2024

 

September 27, 2025

 

September 28, 2024

Net income (loss)

$

(19,148

)

 

$

(31,925

)

 

$

15,954

 

 

$

(91,032

)

 

$

(84,672

)

Interest income

 

(8,085

)

 

 

(8,373

)

 

 

(9,353

)

 

 

(31,456

)

 

 

(36,907

)

Income tax (benefit) expense

 

(423

)

 

 

44

 

 

 

4,110

 

 

 

(1,627

)

 

 

4,212

 

Depreciation and amortization

 

8,648

 

 

 

12,940

 

 

 

5,780

 

 

 

39,617

 

 

 

20,845

 

Stock-based compensation

 

53,852

 

 

 

50,279

 

 

 

26,100

 

 

 

180,834

 

 

 

120,608

 

Business combination transaction expenses

 

40

 

 

 

422

 

 

 

324

 

 

 

7,562

 

 

 

324

 

Joint venture formation fees

 

 

 

 

 

 

 

 

 

 

 

 

 

1,089

 

Restructuring charges

 

6,103

 

 

 

16,361

 

 

 

(775

)

 

 

22,233

 

 

 

33,431

 

Internal control remediation

 

1,360

 

 

 

1,795

 

 

 

 

 

8,406

 

 

 

 

Business transformation costs

 

1,210

 

 

 

75

 

 

 

 

 

3,685

 

 

 

 

Fair value adjustments on strategic investments

 

 

 

 

 

 

 

 

 

(4,481

)

 

 

 

Equity financing transaction costs

 

 

 

 

 

 

 

 

 

 

 

 

 

1,985

 

Equity method investment

 

5,885

 

 

 

3,776

 

 

 

240

 

 

 

13,716

 

 

 

777

 

Adjusted EBITDA

$

49,442

 

 

$

45,394

 

 

$

42,380

 

 

$

147,457

 

 

$

61,692

 


The following table reconciles GAAP gross profit to Adjusted gross profit:

 

 

 

 

Three Months Ended

 

Year Ended

 

(in thousands)

September 27, 2025

 

June 28, 2025

 

September 28, 2024

 

September 27, 2025

 

September 28, 2024

Gross profit

$

127,121

 

 

 

$

107,622

 

 

 

$

96,417

 

 

 

$

422,610

 

 

 

$

245,666

 

 

Depreciation

 

1,457

 

 

 

 

3,538

 

 

 

 

2,208

 

 

 

 

10,414

 

 

 

 

7,748

 

 

Stock-based compensation

 

8,672

 

 

 

 

16,034

 

 

 

 

3,260

 

 

 

 

39,678

 

 

 

 

15,654

 

 

Restructuring charges

 

(411

)

 

 

 

 

 

 

 

(775

)

 

 

 

(642

)

 

 

 

33,431

 

 

Adjusted gross profit

$

136,839

 

 

 

$

127,194

 

 

 

$

101,110

 

 

 

$

472,060

 

 

 

$

302,499

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit margin

 

20.6

 

%

 

 

18.2

 

%

 

 

17.1

 

%

 

 

18.8

 

%

 

 

13.7

 

%

Adjusted gross profit margin

 

22.1

 

%

 

 

21.5

 

%

 

 

17.9

 

%

 

 

21.0

 

%

 

 

16.9

 

%


The following table reconciles GAAP research and development expenses to Adjusted research and development expenses:

 

 

Three Months Ended

 

Year Ended

(in thousands)

September 27, 2025

 

June 28, 2025

 

September 28, 2024

 

September 27, 2025

 

September 28, 2024

Research and development expenses

$

58,732

 

 

$

52,147

 

 

$

40,130

 

 

$

216,013

 

 

$

173,457

 

Depreciation and amortization

 

(4,946

)

 

 

(7,133

)

 

 

(1,647

)

 

 

(19,990

)

 

 

(4,883

)

Stock-based compensation

 

(16,494

)

 

 

(12,860

)

 

 

(11,553

)

 

 

(57,213

)

 

 

(53,266

)

Adjusted research and development expenses

$

37,292

 

 

$

32,154

 

 

$

26,930

 

 

$

138,810

 

 

$

115,308

 


The following table reconciles GAAP selling, general, and administrative expenses to Adjusted selling, general, and administrative expenses:

 

 

Three Months Ended

 

Year Ended

(in thousands)

September 27, 2025

 

June 28, 2025

 

September 28, 2024

 

September 27, 2025

 

September 28, 2024

Selling, general, and administrative expenses

$

83,638

 

 

$

75,670

 

 

$

45,399

 

 

$

298,730

 

 

$

188,934

 

Depreciation and amortization

 

(2,245

)

 

 

(2,270

)

 

 

(1,926

)

 

 

(9,214

)

 

 

(8,220

)

Stock-based compensation

 

(28,686

)

 

 

(21,385

)

 

 

(11,286

)

 

 

(83,943

)

 

 

(51,686

)

Business combination transaction expenses

 

(40

)

 

 

(422

)

 

 

(324

)

 

 

(7,562

)

 

 

(324

)

Internal control remediation

 

(1,359

)

 

 

(1,795

)

 

 

 

 

 

(8,406

)

 

 

 

Business transformation costs

 

(1,210

)

 

 

(75

)

 

 

 

 

 

(3,685

)

 

 

 

Joint venture formation fees

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,089

)

Equity financing transaction costs

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,985

)

Adjusted selling, general, and administrative expenses

$

50,098

 

 

$

49,723

 

 

$

31,863

 

 

$

185,920

 

 

$

125,630

 


The following table reconciles GAAP net cash provided by (used in) operating activities to free cash flow:

 

 

Three Months Ended

 

Year Ended

(in thousands)

September 27, 2025

 

June 28, 2025

 

September 28, 2024

 

September 27, 2025

 

September 28, 2024

Net cash provided by (used in) operating activities

$

530,680

 

 

$

(138,343

)

 

$

(99,383

)

 

$

866,939

 

 

$

(58,077

)

Purchases of property and equipment and capitalization of internal use software development costs

 

(36,246

)

 

 

(14,867

)

 

 

(21,367

)

 

 

(79,030

)

 

 

(44,374

)

Free cash flow

$

494,434

 

 

$

(153,210

)

 

$

(120,750

)

 

$

787,909

 

 

$

(102,451

)


 

Symbotic Inc. and Subsidiaries
Supplemental Common Share Information

 

Total Common Shares issued and outstanding:

 

 

September 27, 2025

 

September 28, 2024

Class A Common Shares issued and outstanding

112,635,932

 

 

104,689,377

 

Class V-1 Common Shares issued and outstanding

74,693,311

 

 

76,965,386

 

Class V-3 Common Shares issued and outstanding

403,559,196

 

 

404,309,196

 

 

590,888,439

 

 

585,963,959

 


 

Symbotic Inc. and Subsidiaries
Consolidated Balance Sheets

 

(in thousands, except share data)

September 27, 2025

 

September 28, 2024

ASSETS

Current assets:

 

 

 

Cash and cash equivalents

$

1,244,993

 

 

$

727,310

 

Accounts receivable

 

186,705

 

 

 

201,548

 

Unbilled accounts receivable

 

181,658

 

 

 

218,233

 

Inventories

 

164,390

 

 

 

106,136

 

Deferred expenses

 

20,532

 

 

 

1,058

 

Prepaid expenses and other current assets

 

92,050

 

 

 

101,252

 

Total current assets

 

1,890,328

 

 

 

1,355,537

 

Property and equipment, net

 

117,649

 

 

 

97,109

 

Intangible assets, net

 

79,149

 

 

 

3,664

 

Goodwill

 

59,871

 

 

 

 

Equity method investment

 

123,034

 

 

 

81,289

 

Other assets

 

131,166

 

 

 

40,953

 

Total assets

$

2,401,197

 

 

$

1,578,552

 

LIABILITIES AND EQUITY

Current liabilities:

 

 

 

Accounts payable

$

286,669

 

 

$

175,188

 

Accrued expenses and other current liabilities

 

200,442

 

 

 

165,644

 

Deferred revenue

 

1,242,312

 

 

 

676,314

 

Total current liabilities

 

1,729,423

 

 

 

1,017,146

 

Deferred revenue

 

124,932

 

 

 

129,233

 

Other liabilities

 

63,629

 

 

 

42,043

 

Total liabilities

 

1,917,984

 

 

 

1,188,422

 

Commitments and contingencies

 

 

 

 

 

Equity:

 

 

 

Class A Common Stock, 3,000,000,000 shares authorized, 112,635,932 and 104,689,377 shares issued and outstanding at September 27, 2025 and September 28, 2024, respectively

 

13

 

 

 

13

 

Class V-1 Common Stock, 1,000,000,000 shares authorized, 74,693,311 and 76,965,386 shares issued and outstanding at September 27, 2025 and September 28, 2024, respectively

 

7

 

 

 

7

 

Class V-3 Common Stock, 450,000,000 shares authorized, 403,559,196 and 404,309,196 shares issued and outstanding at September 27, 2025 and September 28, 2024, respectively

 

40

 

 

 

40

 

Additional paid-in capital

 

1,564,815

 

 

 

1,523,692

 

Accumulated deficit

 

(1,340,862

)

 

 

(1,323,925

)

Accumulated other comprehensive loss

 

(2,695

)

 

 

(2,594

)

Total stockholders' equity

 

221,318

 

 

 

197,233

 

Noncontrolling interest

 

261,895

 

 

 

192,897

 

Total equity

 

483,213

 

 

 

390,130

 

Total liabilities and equity

$

2,401,197

 

 

$

1,578,552

 


 

Symbotic Inc. and Subsidiaries
Consolidated Statements of Cash Flows

 

 

Three Months Ended

 

Year Ended

(in thousands)

September 27, 2025

 

June 28, 2025

 

September 28, 2024

 

September 27, 2025

 

September 28, 2024

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

Net income (loss)

$

(19,148

)

 

$

(31,925

)

 

$

15,954

 

 

$

(91,032

)

 

$

(84,672

)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

8,650

 

 

 

12,941

 

 

 

5,781

 

 

 

39,604

 

 

 

20,847

 

Amortization of leases

 

1,353

 

 

 

1,261

 

 

 

651

 

 

 

4,525

 

 

 

2,633

 

Restructuring of leases

 

3,469

 

 

 

 

 

 

 

 

 

3,469

 

 

 

 

Loss from equity method investment

 

5,885

 

 

 

3,776

 

 

 

240

 

 

 

13,716

 

 

 

777

 

Foreign currency (gains) losses, net

 

40

 

 

 

(61

)

 

 

 

 

 

(33

)

 

 

(8

)

Loss on disposal of assets

 

63

 

 

 

 

 

 

337

 

 

 

264

 

 

 

337

 

Gain on investments

 

 

 

 

 

 

 

 

 

 

 

 

 

(10,084

)

Provision for excess and obsolete inventory

 

2,247

 

 

 

3,921

 

 

 

(775

)

 

 

7,148

 

 

 

33,330

 

Deferred taxes, net

 

(4,205

)

 

 

 

 

 

3,917

 

 

 

(4,205

)

 

 

3,917

 

Stock-based compensation

 

64,368

 

 

 

49,440

 

 

 

25,350

 

 

 

183,936

 

 

 

112,208

 

Gain from strategic investment fair value adjustment

 

 

 

 

 

 

 

 

 

 

(4,481

)

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

Accounts receivable

 

(50,495

)

 

 

1,389

 

 

 

(101,010

)

 

 

15,075

 

 

 

(132,305

)

Inventories

 

(28,690

)

 

 

3,470

 

 

 

30,202

 

 

 

(58,876

)

 

 

103

 

Prepaid expenses and other current assets

 

7,685

 

 

 

(37,107

)

 

 

(114,889

)

 

 

70,386

 

 

 

(112,050

)

Deferred expenses

 

(1,589

)

 

 

27,503

 

 

 

5,690

 

 

 

21,993

 

 

 

(4,936

)

Other assets

 

25,624

 

 

 

(9,449

)

 

 

(4,088

)

 

 

8,696

 

 

 

(9,040

)

Accounts payable

 

56,360

 

 

 

(4,407

)

 

 

47,399

 

 

 

96,904

 

 

 

65,270

 

Accrued expenses and other current liabilities

 

17,969

 

 

 

12,532

 

 

 

(10,126

)

 

 

10,356

 

 

 

38,467

 

Deferred revenue

 

489,118

 

 

 

(171,331

)

 

 

6,309

 

 

 

606,406

 

 

 

18,318

 

Acquisition-related consideration paid to customer

 

(45,000

)

 

 

 

 

 

 

 

 

(45,000

)

 

 

 

Other liabilities

 

(3,024

)

 

 

(296

)

 

 

(10,325

)

 

 

(11,912

)

 

 

(1,189

)

Net cash provided by (used in) operating activities

 

530,680

 

 

 

(138,343

)

 

 

(99,383

)

 

 

866,939

 

 

 

(58,077

)

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

Purchases of property and equipment and capitalization of software development costs

 

(36,246

)

 

 

(14,867

)

 

 

(21,367

)

 

 

(79,030

)

 

 

(44,374

)

Proceeds from maturities of marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

340,000

 

Purchases of marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

(48,660

)

Acquisitions of strategic investments

 

(87,656

)

 

 

(24,233

)

 

 

(23,996

)

 

 

(129,881

)

 

 

(90,485

)

Cash paid for business acquisitions

 

58,169

 

 

 

 

 

 

 

 

 

(141,831

)

 

 

 

Net cash provided by (used in) investing activities

 

(65,733

)

 

 

(39,100

)

 

 

(45,363

)

 

 

(350,742

)

 

 

156,481

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

Payment for taxes related to net share settlement of stock-based compensation awards

 

 

 

 

 

 

 

 

 

 

(3,012

)

 

 

(3,181

)

Net proceeds from issuance of common stock under employee stock purchase plan

 

1,622

 

 

 

 

 

 

2,308

 

 

 

4,855

 

 

 

5,743

 

Proceeds from issuance of Class A Common Stock

 

 

 

 

 

 

 

 

 

 

 

 

 

257,985

 

Distributions to or on behalf of Symbotic Holdings LLC partners

 

 

 

 

57

 

 

 

(561

)

 

 

(1,175

)

 

 

(48,215

)

Proceeds from exercise of warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

158,704

 

Net cash provided by financing activities

 

1,622

 

 

 

57

 

 

 

1,747

 

 

 

668

 

 

 

371,036

 

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

 

(16

)

 

 

24

 

 

 

21

 

 

 

(26

)

 

 

(4

)

Net increase (decrease) in cash, cash equivalents, and restricted cash

 

466,553

 

 

 

(177,362

)

 

 

(142,978

)

 

 

516,839

 

 

 

469,436

 

Cash, cash equivalents, and restricted cash - beginning of period

 

780,640

 

 

 

958,002

 

 

 

873,332

 

 

 

730,354

 

 

 

260,918

 

Cash, cash equivalents, and restricted cash - end of period

$

1,247,193

 

 

$

780,640

 

 

$

730,354

 

 

$

1,247,193

 

 

$

730,354

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Year Ended

(in thousands)

September 27, 2025

 

June 28, 2025

 

September 28, 2024

 

September 27, 2025

 

September 28, 2024

Reconciliation of cash, cash equivalents, and restricted cash:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

$

1,244,993

 

 

$

777,576

 

 

$

727,310

 

 

$

1,244,993

 

 

$

727,310

 

Restricted cash

 

2,200

 

 

 

3,064

 

 

 

3,044

 

 

 

2,200

 

 

 

3,044

 

Cash, cash equivalents, and restricted cash

$

1,247,193

 

 

$

780,640

 

 

$

730,354

 

 

$

1,247,193

 

 

$

730,354